How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Pharma and Healthcare · Forecast 2027–2033
Dental Contra angles Market
- By Product Type: Fiber Optic Contra Angles, Non-Fiber Optic Contra Angles, Electric Contra Angles, Air-Driven Contra Angles, Surgical Contra Angles
- By Connection Type: ISO Connection, KaVo Connection, Sirona Connection, NSK Connection, W&H Connection
- By Speed Range: Low Speed (Below 20,000 RPM), High Speed (Above 20,000 RPM)
- By Application: Restorative Dentistry, Endodontics, Oral Surgery, Prosthodontics, Periodontics
- By Material: Stainless Steel, Titanium, Plastic Composite
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Projected to reach $X,XXX.XM by 2033 on sustained demand. Market Outlook →
- 03 Growth - X.XX% CAGR across 2027–2033, with the full year-by-year model inside. Market Outlook →
- 04 Leading segment - Fiber Optic Contra Angles leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 296 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.178 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.186 →
Full report · locked preview
Everything inside the Dental Contra angles Market report
A complete, evidence-based study - 12 chapters and 124 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Companies profiled
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Dentsply Sirona
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →KaVo Kerr
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →NSK Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →W&H Dentalwerk Bürmoos GmbH
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Bien-Air Dental SA
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →A-dec Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Morita Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Planmeca Oy
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →B. Braun Melsungen AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Stern Weber S.p.A.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Coxo Dental Instruments Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →DentalEZ Group
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Hu-Friedy Mfg. Co.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →LLC
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Anhui Huanyu Medical Instrument Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Shanghai United Imaging Healthcare Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Fiber Optic Contra Angles50.9
- Non-Fiber Optic Contra Angles15.6
- Electric Contra Angles12.4
- Air-Driven Contra Angles13.9
- Surgical Contra Angles7.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Dentsply Sirona19.3
- KaVo Kerr16.0
- NSK Ltd.6.4
- W&H Dentalwerk Bürmoos GmbH12.9
- Bien-Air Dental SA6.8
- A-dec Inc.10.6
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America36.8
- Europe21.2
- Asia Pacific20.1
- Latin America12.1
- Middle East and Africa9.9
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Dentsply Sirona | 81 | 80 | 96 | 79 | 75 | 96 | 85 |
| KaVo Kerr | 86 | 81 | 85 | 70 | 70 | 68 | 77 |
| NSK Ltd. | 73 | 76 | 74 | 86 | 73 | 68 | 75 |
| W&H Dentalwerk Bürmoos GmbH | 70 | 62 | 76 | 67 | 60 | 82 | 70 |
| Bien-Air Dental SA | 72 | 75 | 66 | 70 | 60 | 67 | 68 |
| A-dec Inc. | 67 | 60 | 51 | 60 | 61 | 60 | 60 |
| Morita Corporation | 45 | 62 | 64 | 51 | 46 | 64 | 55 |
| Planmeca Oy | 40 | 40 | 38 | 49 | 36 | 56 | 43 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Dentsply Sirona
- KaVo Kerr
- NSK Ltd.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Dentsply Sirona | ✓ | ◐ | ✓ | ✓ | ◐ | ◐ |
| KaVo Kerr | ◐ | ◐ | ◐ | ◐ | ✓ | ◐ |
| NSK Ltd. | − | ◐ | ✓ | ◐ | ✓ | − |
| W&H Dentalwerk Bürmoos GmbH | − | − | ✓ | ✓ | ◐ | ✓ |
| Bien-Air Dental SA | ◐ | ◐ | ◐ | ◐ | − | ◐ |
| A-dec Inc. | ◐ | − | ◐ | ◐ | − | ◐ |
| Morita Corporation | − | ◐ | − | − | − | − |
| Planmeca Oy | − | − | − | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
Challenger4
Strong scale, closing on the leaders.
Contender1
Focused players with pockets of strength.
Niche2
Specialists in a single segment or region.
Go-to-market strategy
Land Product Type in North America, then scale across Dental Contra angles Market — a $390M beachhead inside a $5.81B market.
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Fiber Optic Contra Angles
Best fit — highest urgency & budget in Product Type.
Non-Fiber Optic Contra Angles
Strong fit — clear ROI and a fast path to value.
Electric Contra Angles
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Connection Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Speed Range
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Dental Contra angles Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Investment thesis
Dental Contra angles Market is a durable-growth opportunity — $2.97B by 2033, compounding at 7.2%.
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →7.2% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →Return scenarios (2033 market value)
Fig. 6 · p.22 →Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Connection Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Dental Contra angles Market — a $2.15B market by 2033. Plan: grow share from 9.1% to 17.5%.
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.1% | 17.5% | On track |
| Revenue | $185M | $376M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 31.1% | 40.8% | On track |
| Customer retention | 84.0% | 95.5% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
Adjacency
Build Connection Type capability
A defensible second engine — invest in Connection Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Connection Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $39M capacity & capability investment
- Greenlight bolt-on M&A in Connection Type
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossAt risk
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentOn track
Sales deck · value proposition
Win the Dental Contra angles Market conversation — a $4.72B market you can size, segment and defend in minutes.
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →The business case (ROI)
Fig. 2 · p.9 →Why buyers trust it (proof points)
§1.3 · p.12 →Coverage includes
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Dental Contra angles Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
Your report is ready to access
Dental Contra angles Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Pharma and Healthcare · scroll →Dental Turbines Market
Market size, share, segmentation and regional forecast.
$3.3B by 2032 · 7.38% CAGR
View reportLivestock Vaccine Market
Market size, share, segmentation and regional forecast.
$1.9B by 2032 · 10.60% CAGR
View reportStatins Market
Market size, share, segmentation and regional forecast.
$12.4B by 2032 · 6.09% CAGR
View reportCancer Vaccine Market
Market size, share, segmentation and regional forecast.
$1.7B by 2031 · 6.02% CAGR
View reportOperating Microscopes Market
Market size, share, segmentation and regional forecast.
$14.9B by 2032 · 3.33% CAGR
View reportOpioid Induced Constipation (OIC) Drug Market
Market size, share, segmentation and regional forecast.
$14.9B by 2031 · 8.48% CAGR
View reportChronic Idiopathic Constipation (CIC) Drugs Market
Market size, share, segmentation and regional forecast.
$4.5B by 2032 · 6.61% CAGR
View reportFoam Wound Dressing Market
Market size, share, segmentation and regional forecast.
$2.7B by 2031 · 4.41% CAGR
View reportAptamers Market
Market size, share, segmentation and regional forecast.
$983M by 2033 · 10.51% CAGR
View reportAllergy Rhinitis Drugs Market
Market size, share, segmentation and regional forecast.
$12.3B by 2033 · 7.78% CAGR
View reportArtemisinine Market
Market size, share, segmentation and regional forecast.
$1.5B by 2031 · 5.96% CAGR
View reportSpecialty Pharmaceutical Market
Market size, share, segmentation and regional forecast.
$2.9B by 2031 · 5.72% CAGR
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy